Evidence map›Paper›PMID 36312285›Full record

ArticleFrontiers in cardiovascular medicine2022

Case report: A case of isolated cardiac sarcoidosis diagnosed by multimodal imaging and endomyocardial biopsy.

Yongling Wa, Xiaowei Niu, Jizhe Xu, Gaxue Jiang, Sixiong Hu, Ming Bai

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. High-risk and low prevalence disease: Cardiac sarcoidosis and some of its mimics.International journal of cardiology. Heart & vasculature · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yongling WaDepartment of Cardiology, First Hospital of Lanzhou University, Lanzhou, China.
Xiaowei NiuDepartment of Cardiology, First Hospital of Lanzhou University, Lanzhou, China.
Jizhe XuDepartment of Cardiology, First Hospital of Lanzhou University, Lanzhou, China.
Gaxue JiangDepartment of Cardiology, First Hospital of Lanzhou University, Lanzhou, China.
Sixiong HuDepartment of Cardiology, First Hospital of Lanzhou University, Lanzhou, China.
Ming BaiDepartment of Cardiology, First Hospital of Lanzhou University, Lanzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to its low incidence, isolated cardiac sarcoidosis (ICS) is often missed or misdiagnosed. Herein, we describe a case of ICS in a 52-year-old male patient. Advanced imaging, including cardiac magnetic resonance (CMR) and fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET), could not only screen high-risk patients for establishing diagnosis, but also guide endomyocardial biopsy (EMB) for improving cardiac disease detection rate. This case highlights the importance of multimodal imaging for screening and necessity of EMB for diagnosis.

Indexed as

cardiovascular imaging (CARD)CMR (cardiovascular magnetic resonance)FDG (18F-fluorodeoxyglucose)-PET/CTisolated cardiac sarcoidosismultimodal imagingmyocardial endocardial biopsy

Identifiers

PMID36312285
PMCPMC9613964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.